Effects of anti-androgen treatment on the catecholamine synthetic pathway in the adrenal medulla of spontaneously hypertensive rats

Toshio Kumai, Masami Tanaka, Tomonori Tateishi, Minoru Watanabe, Hironori Nakura, Masako Asoh, Shinichi Kobayashi

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

We investigated the effects of the antiandrogen flutamide on the activity of tyrosine hydroxylase, the levels of its encoding mRNA, and catecholamine levels in the adrenal medulla of male spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY). Flutamide (30 mg/kg) was administered subcutaneously daily (between 9 and 15 weeks of age). The systolic blood pressure of flutamide-treated SHR rats was lower than that of control SHR. Epinephrine and norepinephrine levels, tyrosine hydroxylase activity, and the levels of encoding mRNA in the adrenal medulla were significantly lower in flutamide-treated SHR rats than in paired controls. Systolic blood pressure, epinephrine and norepinephrine levels, tyrosine hydroxylase activity, and encoding mRNA in the adrenal medulla of WKY rats showed no significant differences between flutamide-treated and control groups. These findings suggested that flutamide may have cardiovascular effects through alteration of the catecholamine synthetic pathway caused by removal of androgen receptor stimulation on the expression of tyrosine hydroxylase in the adrenal medulla of male SHR rats.

Original languageEnglish
Pages (from-to)620-624
Number of pages5
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume357
Issue number6
DOIs
Publication statusPublished - 1998
Externally publishedYes

Fingerprint

Flutamide
Adrenal Medulla
Inbred SHR Rats
Androgens
Catecholamines
Tyrosine 3-Monooxygenase
Blood Pressure
Inbred WKY Rats
Messenger RNA
Epinephrine
Norepinephrine
Androgen Antagonists
Androgen Receptors
Control Groups

Keywords

  • Adrenal medulla
  • Antiandrogen
  • Blood pressure
  • Catecholamine
  • SHR inbred
  • Tyrosine hydroxylase

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of anti-androgen treatment on the catecholamine synthetic pathway in the adrenal medulla of spontaneously hypertensive rats. / Kumai, Toshio; Tanaka, Masami; Tateishi, Tomonori; Watanabe, Minoru; Nakura, Hironori; Asoh, Masako; Kobayashi, Shinichi.

In: Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 357, No. 6, 1998, p. 620-624.

Research output: Contribution to journalArticle

Kumai, Toshio ; Tanaka, Masami ; Tateishi, Tomonori ; Watanabe, Minoru ; Nakura, Hironori ; Asoh, Masako ; Kobayashi, Shinichi. / Effects of anti-androgen treatment on the catecholamine synthetic pathway in the adrenal medulla of spontaneously hypertensive rats. In: Naunyn-Schmiedeberg's Archives of Pharmacology. 1998 ; Vol. 357, No. 6. pp. 620-624.
@article{0fd01e5c191345ec84b8c95d498b8da4,
title = "Effects of anti-androgen treatment on the catecholamine synthetic pathway in the adrenal medulla of spontaneously hypertensive rats",
abstract = "We investigated the effects of the antiandrogen flutamide on the activity of tyrosine hydroxylase, the levels of its encoding mRNA, and catecholamine levels in the adrenal medulla of male spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY). Flutamide (30 mg/kg) was administered subcutaneously daily (between 9 and 15 weeks of age). The systolic blood pressure of flutamide-treated SHR rats was lower than that of control SHR. Epinephrine and norepinephrine levels, tyrosine hydroxylase activity, and the levels of encoding mRNA in the adrenal medulla were significantly lower in flutamide-treated SHR rats than in paired controls. Systolic blood pressure, epinephrine and norepinephrine levels, tyrosine hydroxylase activity, and encoding mRNA in the adrenal medulla of WKY rats showed no significant differences between flutamide-treated and control groups. These findings suggested that flutamide may have cardiovascular effects through alteration of the catecholamine synthetic pathway caused by removal of androgen receptor stimulation on the expression of tyrosine hydroxylase in the adrenal medulla of male SHR rats.",
keywords = "Adrenal medulla, Antiandrogen, Blood pressure, Catecholamine, SHR inbred, Tyrosine hydroxylase",
author = "Toshio Kumai and Masami Tanaka and Tomonori Tateishi and Minoru Watanabe and Hironori Nakura and Masako Asoh and Shinichi Kobayashi",
year = "1998",
doi = "10.1007/PL00005216",
language = "English",
volume = "357",
pages = "620--624",
journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",
issn = "0028-1298",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Effects of anti-androgen treatment on the catecholamine synthetic pathway in the adrenal medulla of spontaneously hypertensive rats

AU - Kumai, Toshio

AU - Tanaka, Masami

AU - Tateishi, Tomonori

AU - Watanabe, Minoru

AU - Nakura, Hironori

AU - Asoh, Masako

AU - Kobayashi, Shinichi

PY - 1998

Y1 - 1998

N2 - We investigated the effects of the antiandrogen flutamide on the activity of tyrosine hydroxylase, the levels of its encoding mRNA, and catecholamine levels in the adrenal medulla of male spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY). Flutamide (30 mg/kg) was administered subcutaneously daily (between 9 and 15 weeks of age). The systolic blood pressure of flutamide-treated SHR rats was lower than that of control SHR. Epinephrine and norepinephrine levels, tyrosine hydroxylase activity, and the levels of encoding mRNA in the adrenal medulla were significantly lower in flutamide-treated SHR rats than in paired controls. Systolic blood pressure, epinephrine and norepinephrine levels, tyrosine hydroxylase activity, and encoding mRNA in the adrenal medulla of WKY rats showed no significant differences between flutamide-treated and control groups. These findings suggested that flutamide may have cardiovascular effects through alteration of the catecholamine synthetic pathway caused by removal of androgen receptor stimulation on the expression of tyrosine hydroxylase in the adrenal medulla of male SHR rats.

AB - We investigated the effects of the antiandrogen flutamide on the activity of tyrosine hydroxylase, the levels of its encoding mRNA, and catecholamine levels in the adrenal medulla of male spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY). Flutamide (30 mg/kg) was administered subcutaneously daily (between 9 and 15 weeks of age). The systolic blood pressure of flutamide-treated SHR rats was lower than that of control SHR. Epinephrine and norepinephrine levels, tyrosine hydroxylase activity, and the levels of encoding mRNA in the adrenal medulla were significantly lower in flutamide-treated SHR rats than in paired controls. Systolic blood pressure, epinephrine and norepinephrine levels, tyrosine hydroxylase activity, and encoding mRNA in the adrenal medulla of WKY rats showed no significant differences between flutamide-treated and control groups. These findings suggested that flutamide may have cardiovascular effects through alteration of the catecholamine synthetic pathway caused by removal of androgen receptor stimulation on the expression of tyrosine hydroxylase in the adrenal medulla of male SHR rats.

KW - Adrenal medulla

KW - Antiandrogen

KW - Blood pressure

KW - Catecholamine

KW - SHR inbred

KW - Tyrosine hydroxylase

UR - http://www.scopus.com/inward/record.url?scp=0031806234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031806234&partnerID=8YFLogxK

U2 - 10.1007/PL00005216

DO - 10.1007/PL00005216

M3 - Article

C2 - 9686937

AN - SCOPUS:0031806234

VL - 357

SP - 620

EP - 624

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

SN - 0028-1298

IS - 6

ER -